View by type:
Articles (4215)
500,000 doses of Ebola vaccine to be made available to countries for outbreak response
A Gavi-funded global emergency stockpile of Ebola vaccines will be accessible to all countries following a procurement process concluded by UNICEF
COVID-19 immunity: how long does it last?
Long-term protection will depend on the 'memory response' developed by our immune systems – and the initial signs are promising.
COVID-19 vaccines are set to become the quickest vaccines in history to go from initial trials to rollout, but what lessons can we learn from its speedy predecessor: the Ebola vaccine?
Lessons from Rwanda’s Fight Against COVID-19
While some of the world's richest and most technologically advanced countries have struggled to contain the spread and morbidity of COVID-19, Rwanda has set a shining example of how to manage a pandemic and safeguard public health. Chief among…
Why delivering COVID-19 vaccines might be just as hard as developing them
From Liability Laws to Production Delays, the 2009 H1N1 Swine Flu Vaccine Rollout Offers a Cautionary Tale for Today.
Coronavirus: few vaccines prevent infection – here’s why that’s not a problem
Sterilising immunity means that the immune system is able to completely prevent a virus from replicating in your body. Not all vaccines provide this.
Trekking through the snow to deliver vaccines
Vaccinators tackle winter conditions and challenging contexts during Afghanistan’s last polio campaign of the year.
COVID-19 comes as a double blow to those living with HIV
In March 2020, as soon as the first cases of COVID-19 were detected in Kyrgyzstan, a state of emergency was declared, and the country went into lockdown.
Can Poor Countries Avoid a Vaccine Bidding War?
For all of the good news about the arrival of safe and effective COVID-19 vaccines, the hard truth for the coming year is that global demand will outpace supply. Without a multilateral agreement to allocate doses globally, the road to recovery…
Is altering the dosing strategy of COVID-19 vaccines a good idea?
Uncertainty in the availability of vaccine doses is prompting some countries to consider altering dosing schedules, or mixing different vaccine types. How could this impact the effectiveness of vaccines?
COVID-19 FAQs: The 10 questions you need to know the answer to
We believe the best way to address misconceptions is to arm yourself with the facts and have a few key points and statistics. Here’s our list of facts to combat common misinformation.
Coronavirus vaccines: how will we know when life can go back to normal?
Here's what we still need to find out before we can know when we'll be able to return to our pre-coronavirus ways.